Melisa M. Shah
YOU?
Author Swipe
View article: Cost-Effectiveness of 2023-2024 COVID-19 Vaccination in US Adults
Cost-Effectiveness of 2023-2024 COVID-19 Vaccination in US Adults Open
Importance Evidence is needed on the economic favorability of a 2023-2024 COVID-19 vaccination program to support policy decisions on recommendations for COVID-19 vaccination. Objective To measure the cost-effectiveness of vaccination with…
View article: COVID-19 Antiviral Treatment: Examining Knowledge, Access, Trust in Sources of information and Willingness to Use Among Essential Workers
COVID-19 Antiviral Treatment: Examining Knowledge, Access, Trust in Sources of information and Willingness to Use Among Essential Workers Open
View article: Recommended immunizations to reduce respiratory morbidity and mortality among US adults with asthma, by age
Recommended immunizations to reduce respiratory morbidity and mortality among US adults with asthma, by age Open
View article: Long-Term Symptoms Associated With SARS-CoV-2 Infection Among Blood Donors
Long-Term Symptoms Associated With SARS-CoV-2 Infection Among Blood Donors Open
Importance Long-term symptoms, lasting more than 4 consecutive weeks after acute COVID-19 disease, are an important consequence of SARS-CoV-2 infection. Many prior studies have lacked a non–SARS-CoV-2–infected control population to disting…
View article: Combined Protection of Vaccination and Nirmatrelvir-Ritonavir Against Hospitalization in Adults With COVID-19
Combined Protection of Vaccination and Nirmatrelvir-Ritonavir Against Hospitalization in Adults With COVID-19 Open
Among adults at risk for severe coronavirus disease 2019 (COVID-19), the lowest hospitalization rate was among those who received nirmatrelvir-ritonavir after 3 or more messenger RNA vaccine doses (adjusted hazard ratio, 0.22; 95% confiden…
View article: Prevalence of SARS‐CoV‐2 infection among US blood donors by industry, May–December 2021
Prevalence of SARS‐CoV‐2 infection among US blood donors by industry, May–December 2021 Open
Background Work is a social determinant of health that is often overlooked. There are major work‐related differences in the risk of severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infection and death, but there have been few a…
View article: Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023
Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023 Open
COVID-19 vaccines protect against severe COVID-19-associated outcomes, including hospitalization and death. As SARS-CoV-2 has evolved, and waning vaccine effectiveness has been noted, vaccine formulations and policies have been updated to …
View article: Seasonality of Common Human Coronaviruses, United States, 2014–20211
Seasonality of Common Human Coronaviruses, United States, 2014–20211 Open
The 4 common types of human coronaviruses (HCoVs)-2 alpha (HCoV-NL63 and HCoV-229E) and 2 beta (HCoV-HKU1 and HCoV-OC43)-generally cause mild upper respiratory illness. Seasonal patterns and annual variation in predominant types of HCoVs a…
View article: Mass drug administration for malaria during emergencies, periods of health service disruption, or epidemics of febrile illness
Mass drug administration for malaria during emergencies, periods of health service disruption, or epidemics of febrile illness Open
Report considered by the WHO/GMP Guideline Development Group on Malaria Chemoprevention for “Section 4.2.6.2 MDA for burden reduction in emergency settings” of the WHO Guidelines for malaria, 3 June 2022.
View article: Mass drug administration for malaria burden reduction
Mass drug administration for malaria burden reduction Open
Report considered by the WHO/GMP Guideline Development Group on Malaria Chemoprevention for “Section 4.2.6.1 MDA for burden reduction” of the WHO Guidelines for malaria, 3 June 2022.
View article: Seasonality of Common Human Coronaviruses in the United States, 2014-2021
Seasonality of Common Human Coronaviruses in the United States, 2014-2021 Open
The four common human coronaviruses (HCoVs), including two alpha (HCoV-NL63 and HCoV-229E) and two beta (HCoV-HKU1 and HCoV-OC43) types, generally cause mild, upper respiratory illness. HCoVs are known to have seasonal patterns and variati…
View article: Relationship of SARS-CoV-2 Antigen and Reverse Transcription PCR Positivity for Viral Cultures
Relationship of SARS-CoV-2 Antigen and Reverse Transcription PCR Positivity for Viral Cultures Open
We assessed the relationship between antigen and reverse transcription PCR (RT-PCR) test positivity and successful virus isolation. We found that antigen test results were more predictive of virus recovery than RT-PCR results. However, vir…
View article: Quantitative comparison of SARS-CoV-2 nucleic acid amplification test and antigen testing algorithms: a decision analysis simulation model
Quantitative comparison of SARS-CoV-2 nucleic acid amplification test and antigen testing algorithms: a decision analysis simulation model Open
Background Antigen tests for SARS-CoV-2 offer advantages over nucleic acid amplification tests (NAATs, such as RT-PCR), including lower cost and rapid return of results, but show reduced sensitivity. Public health organizations recommend d…
View article: Twelve-Month Follow-up of Early COVID-19 Cases in the United States: Cellular and Humoral Immune Longevity
Twelve-Month Follow-up of Early COVID-19 Cases in the United States: Cellular and Humoral Immune Longevity Open
We quantify antibody and memory B-cell responses to severe acute respiratory syndrome coronavirus 2 at 6 and 12 months postinfection among 7 unvaccinated US coronavirus disease 2019 cases. All had detectable S-specific memory B cells and i…
View article: Enterovirus D68-Associated Acute Respiratory Illness ─ New Vaccine Surveillance Network, United States, July–November 2018–2020
Enterovirus D68-Associated Acute Respiratory Illness ─ New Vaccine Surveillance Network, United States, July–November 2018–2020 Open
Enterovirus D68 (EV-D68) is associated with a broad spectrum of illnesses, including mild to severe acute respiratory illness (ARI) and acute flaccid myelitis (AFM). Enteroviruses, including EV-D68, are typically detected in the United Sta…
View article: 1331. Seasonality of Common Human Coronaviruses in the United States, 2014-2021
1331. Seasonality of Common Human Coronaviruses in the United States, 2014-2021 Open
Background The four common human coronavirus (HCoV) types, including two alpha (NL63 and 229E) and two beta (HKU1 and OC43) coronaviruses, generally cause mild, upper respiratory illness. Common HCoV seroprevalence increases rapidly during…
View article: Antigen Test Performance Among Children and Adults at a SARS-CoV-2 Community Testing Site
Antigen Test Performance Among Children and Adults at a SARS-CoV-2 Community Testing Site Open
Background Performance characteristics of SARS-CoV-2 antigen tests among children are limited despite the need for point-of-care testing in school and childcare settings. We describe children seeking SARS-CoV-2 testing at a community site …
View article: Characteristics of children and antigen test performance at a SARS-CoV-2 community testing site
Characteristics of children and antigen test performance at a SARS-CoV-2 community testing site Open
Background Performance characteristics of SARS-CoV-2 antigen tests among children are limited despite the need for point-of-care testing in school and childcare settings. We describe children seeking SARS-CoV-2 testing at a community site …
View article: Performance of Repeat BinaxNOW Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Testing in a Community Setting, Wisconsin, November 2020–December 2020
Performance of Repeat BinaxNOW Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Testing in a Community Setting, Wisconsin, November 2020–December 2020 Open
Repeating the BinaxNOW antigen test for severe acute respiratory syndrome coronavirus 2 using 2 groups of readers within 30 minutes resulted in high concordance (98.9%) in 2110 encounters. Same-day repeat antigen testing did not significan…
View article: Performance of Repeat BinaxNOW SARS-CoV-2 Antigen Testing in a Community Setting, Wisconsin, November-December 2020
Performance of Repeat BinaxNOW SARS-CoV-2 Antigen Testing in a Community Setting, Wisconsin, November-December 2020 Open
Repeating the BinaxNOW antigen test for SARS-CoV-2 by two groups of readers within 30 minutes resulted in high concordance (98.9%) in 2,110 encounters. BinaxNOW test sensitivity was 77.2% (258/334) compared to real-time reverse transcripti…
View article: Quantitative Comparison of SARS-CoV-2 Nucleic Acid Amplification Test and Antigen Testing Algorithms: A Decision Analysis Simulation Model
Quantitative Comparison of SARS-CoV-2 Nucleic Acid Amplification Test and Antigen Testing Algorithms: A Decision Analysis Simulation Model Open
Background Antigen tests for SARS-CoV-2 offer advantages over nucleic acid amplification tests (NAATs, such as RT-PCR), including lower cost and rapid return of results, but show reduced sensitivity. Public health organizations continue to…
View article: Shedding of Culturable Virus, Seroconversion, and 6-Month Follow-up Antibody Responses in the First 14 Confirmed Cases of Coronavirus Disease 2019 in the United States
Shedding of Culturable Virus, Seroconversion, and 6-Month Follow-up Antibody Responses in the First 14 Confirmed Cases of Coronavirus Disease 2019 in the United States Open
We aimed to characterize presence of culturable virus in clinical specimens during acute illness, and antibody kinetics up to 6 months after symptom onset, among 14 early patients with coronavirus disease 2019 in the United States. We isol…
View article: Climate predicts geographic and temporal variation in mosquito-borne disease dynamics on two continents
Climate predicts geographic and temporal variation in mosquito-borne disease dynamics on two continents Open
View article: No Evidence of O’nyong-nyong Viremia among Children with Febrile Illness in Kenya (2015–2018)
No Evidence of O’nyong-nyong Viremia among Children with Febrile Illness in Kenya (2015–2018) Open
O’nyong-nyong virus (ONNV) is a little-known arbovirus causing intermittent, yet explosive, outbreaks in Africa. It is closely related to chikungunya virus, an emerging infectious disease. O’nyong-nyong virus causes a self-limited illness …
View article: High Dengue Burden and Circulation of 4 Virus Serotypes among Children with Undifferentiated Fever, Kenya, 2014–2017
High Dengue Burden and Circulation of 4 Virus Serotypes among Children with Undifferentiated Fever, Kenya, 2014–2017 Open
Little is known about the extent and serotypes of dengue viruses circulating in Africa. We evaluated the presence of dengue viremia during 4 years of surveillance (2014-2017) among children with febrile illness in Kenya. Acutely ill febril…
View article: Climate change could shift disease burden from malaria to arboviruses in Africa
Climate change could shift disease burden from malaria to arboviruses in Africa Open
View article: Climate predicts geographic and temporal variation in mosquito-borne disease dynamics on two continents
Climate predicts geographic and temporal variation in mosquito-borne disease dynamics on two continents Open
Climate drives population dynamics through multiple mechanisms, which can lead to seemingly context-dependent effects of climate on natural populations. For climate-sensitive diseases such as dengue, chikungunya, and Zika, climate appears …
View article: Invasive pulmonary aspergillosis and influenza co-infection in immunocompetent hosts: case reports and review of the literature
Invasive pulmonary aspergillosis and influenza co-infection in immunocompetent hosts: case reports and review of the literature Open